Most Recent
Two GPS tracking patents at the heart of a David vs. Goliath battle between Domino's and a Sydney-based startup were foreshadowed by a patent owned by Uber, the pizza chain giant told a court Friday.
As the ACCC's criminal cartel case against ANZ, Citigroup and Deutsche Bank gets underway, the regulator will face off against a formidable team of lawyers with extensive experience in defending competition matters.
If Shine Lawyer's upper damage estimate of $259 million is correct, the funder backing the Westpac life insurance class action would be entitled to a "windfall" of $77 million, the bank told the Federal Court Tuesday.
Generic drug giant Actavis Global has reached a settlement with AstraZeneca in a long-running patent dispute over blockbuster cholesterol medicine Crestor that wound its way to the High Court.
Westpac Banking Corp. engaged in unconscionable conduct when it traded in bank bills in an attempt to influence the benchmark Bank Bill Swap Rate on four occasions, a Federal Court judge ruled Thursday.
The ACCC will face a test of its ability to win misuse of market power cases when a long-awaited judgment is handed down this week in the regulator's appeal of a ruling dismissing its case alleging Pfizer misused its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
Viterra has failed in its third bid to access communications between Cargill Australia and its lawyers related to Cargill's $420 million purchase of malt producer Joe White Maltings from Viterra in 2013.
A two-day hearing has been scheduled in the Westpac life insurance class action over a proposed funding arrangement that would give litigation backer JustKapital 30 per cent of any recovery, in addition to costs outlaid by lawyers for the class.
Taronga Conservation Society Australia and Sydney Zoo have agreed to settle their legal battle over the use of the name "Sydney Zoo".
A Federal Court judge has given the all-clear to a $132.5 million offer by QBE to settle a class action by shareholders angry about a $5 billion stock market wipeout for the insurance provider.